Hosted By
What are the limitations and challenges of pursuing a career outside the traditional career path? How can physicians broaden their conception of what impact really means? In this episode, we answer all these questions and more with our guest, Bobak Azamian, MD.
Bobak is President and CEO of Tarsus Pharmaceuticals, a public biotech company, which revolutionizes therapeutics for essential diseases in eye care, dermatology, and infectious diseases.
Bobak completed an MD from Harvard Medical School (Harvard-MIT Health Sciences and Technology), a PhD in Chemistry from Oxford University as a Rhodes Scholar, and a BA in Physics from Rice University.
How important is it to have a teamwork mentality in medicine? What values does humanitarian work add to someone’s perspective, and how can it...
What are outcome-based payment agreements or VBAs, and how can MDs develop innovative financing models? What do the next few years hold for VBAs...
Dr. Martin-Immanuel Bittner is the CEO of Arctoris, the world's first fully automated drug discovery platform that he co-founded in Oxford in 2016. His...
